# Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life

> **NCT00639301** · — · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 473 (actual)

## Conditions studied

- Retinoblastoma

## Interventions

- **BEHAVIORAL:** Questionnaires

## Key facts

- **NCT ID:** NCT00639301
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2008-03-11
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 473 (ACTUAL)
- **Last updated:** 2026-02-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00639301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00639301, "Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00639301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*